Stephanie L. Lee, MD, PhD

Professor, Medicine

Stephanie Lee
sltal@bu.edu
75 E. Newton St
View full profile at BUMC

Biography

Stephanie L. Lee, Ph.D., M.D., F.A.C.E., E.C.N.U graduated from UC San Diego with a MD and PhD in Physiology and Pharmacology and completed a molecular and clinical fellowship in Endocrinology. Her research interests are to improve the methods to diagnosis and manage thyroid cancer.

Other Positions

  • Member, BU-BMC Cancer Center, Boston University
  • Member, Evans Center for Interdisciplinary Biomedical Research, Boston University

Websites

Education

  • University of California, San Diego, MD
  • University of California, San Diego, PhD
  • University of California, Santa Barbara, BA

Publications

  • Published on 10/31/2022

    Sarkar R, Lee SL, Kumar V, Thakur S. Editorial: Thyroid cancer: New perspectives in diagnosis and therapy. Front Pharmacol. 2022; 13:1057731. PMID: 36386151.

    Read at: PubMed
  • Published on 2/14/2022

    Pence A, McGrath M, Lee SL, Raines DE. Pharmacological management of severe Cushing's syndrome: the role of etomidate. Ther Adv Endocrinol Metab. 2022; 13:20420188211058583. PMID: 35186251.

    Read at: PubMed
  • Published on 5/19/2021

    Goundan PN, Mamou J, Rohrbach D, Smith J, Patel H, Wallace KD, Feleppa EJ, Lee SL. A Preliminary Study of Quantitative Ultrasound for Cancer-Risk Assessment of Thyroid Nodules. Front Endocrinol (Lausanne). 2021; 12:627698. PMID: 34093429.

    Read at: PubMed
  • Published on 12/15/2020

    Haddady S, Pinjic E, Lee SL. Prognostic Value of Serum Thyroglobulin Measured at 48 Hours Versus 72 Hours after Second Dose of Recombinant Human Thyrotropin in Surveillance of Well-Differentiated Thyroid Cancer. Endocr Pract. 2021 Mar; 27(3):216-222. PMID: 33779554.

    Read at: PubMed
  • Published on 12/3/2020

    Vodopivec DM, Thomas DD, Palermo NE, Steenkamp DW, Lee SL. Looking for the Outsider. N Engl J Med. 2020 12 03; 383(23):2275-2281. PMID: 33264549.

    Read at: PubMed
  • Published on 11/1/2020

    Guan H, Toraldo G, Godley FA, Rao SR, Cerda S, McAneny D, Doherty G, Lee SL. The real-world performance of ThyroSeqV.2 to diagnose thyroid "neoplasm requiring surgery". Am J Cancer Res. 2020; 10(11):3838-3851. PMID: 33294271.

    Read at: PubMed
  • Published on 10/1/2020

    Goundan PN, Lee SL. Thyroid effects of amiodarone: clinical update. Curr Opin Endocrinol Diabetes Obes. 2020 10; 27(5):329-334. PMID: 32773570.

    Read at: PubMed
  • Published on 7/23/2020

    Chung R, Guan H, Ponchiardi C, Cerda S, Marwaha N, Yilmaz OH, Pinjic E, McAneny D, Lee SL, Drake FT. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: Epidemiology and Long-Term Outcomes in a Strictly Defined Cohort. Thyroid. 2021 01; 31(1):68-75. PMID: 32539676.

    Read at: PubMed
  • Published on 6/19/2020

    Fazeli SR, Zehr B, Amraei R, Toraldo G, Guan H, Kindelberger D, Lee S, Cerda S. ThyroSeq v2 Testing: Impact on Cytologic Diagnosis, Management, and Cost of Care in Patients with Thyroid Nodule. Thyroid. 2020 10; 30(10):1528-1534. PMID: 32349630.

    Read at: PubMed
  • Published on 2/20/2020

    Guan H, Toraldo G, Cerda S, Godley FA, Rao SR, McAneny D, Doherty G, Braverman L, Lee SL. Utilities of RAS Mutations in Preoperative Fine Needle Biopsies for Decision Making for Thyroid Nodule Management: Results from a Single-Center Prospective Cohort. Thyroid. 2020 04; 30(4):536-547. PMID: 31996097.

    Read at: PubMed

View 62 more publications: View full profile at BUMC

View all profiles